<DOC>
	<DOC>NCT00879684</DOC>
	<brief_summary>The purpose of this study is to determine the safety and tolerability of CVX-060 in patients with advanced solid tumors.</brief_summary>
	<brief_title>Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Confirmed advanced solid tumors unresponsive to currently available therapies or for which there is no standard therapy. Adequate coagulation, liver, and renal function. Candidate for DCEMRI evaluations. ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1. Evidence of significant bleeding problems. History of certain gastrointestinal problems including fistula and abscess. Chronic, uncontrolled hypertension. Patients with any history of primary or metastatic tumor involvement of the brain or with tumors that encase great vessels.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Tumors</keyword>
	<keyword>CVX-060</keyword>
</DOC>